Deferoxamine Therapy and Mucormycosis in Dialysis Patients: Report of an International Registry
- 1 December 1991
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 18 (6) , 660-667
- https://doi.org/10.1016/s0272-6386(12)80606-8
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Disseminated Zygomycosis: Report of Four Cases and ReviewClinical Infectious Diseases, 1989
- Mucormycosis among Patients on DialysisNew England Journal of Medicine, 1989
- Mucormycosis in Patients with Renal FailureRenal Failure, 1989
- Deferoxamine Does Not Increase the Risk for Bacteremia in Hemodialysis PatientsNephron, 1989
- Rapid removal of DFO-chelated aluminum during hemodialysis using polysulfone dialyzersKidney International, 1988
- Adjunctive Hyperbaric Oxygen for Treatment of Rhinocerebral MucormycosisClinical Infectious Diseases, 1988
- Rhinocerebral Mucormycosis in an Anephric PatientSouthern Medical Journal, 1988
- Mucormycosis in a hemodialysis patient with iron overload.Nihon Naika Gakkai Zasshi, 1988
- Fatal Phycomycosis in a Hemodialyzed Patient Receiving DeferoxamineNephron, 1988
- Mucormycosis — A New Risk of Deferoxamine Therapy in Dialysis Patients with Aluminum or Iron Overload?New England Journal of Medicine, 1987